Science

Polycystic ovary syndrome – Hormonal imbalances

Polycystic ovary syndrome (PCOS) is a disorder of the hormone metabolism, which affects around 10% of women in child-bearing age and one of the most common causes of childlessness. PCOS is often associated with further metabolic disorders and they may reinforce each other. Many women suffering from PCOS are overweight, have an increased risk of […]

Science

Fungi in lockdown

Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 5th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany The word Corona is still on everyone’s lips. In the wake of the virus, however, other pathogens are also spreading. Some benefit from the pandemic, among them

Products, Science

EUROPattern Microscope Live – the successful implementation of a smart concept

The launch of the new automatic immunofluorescence microscope EUROPattern Microscope Live is the final step of a development project which was first initiated in 2016 by EUROIMMUN’s founder and former CEO Prof Winfried Stöcker. He had the idea of a smaller version of the established EUROPattern Microscope, a microscope for computer-aided immunofluorescence diagnostics which is

Science

The accursed clinical eye

Guest contribution: Article series on the subject of state-of-the-art mycology in dermatology, 4th article by Prof Hans-Jürgen Tietz, Director of the Institute of Fungal Diseases in Berlin, Germany According to Professor Hans Rieth, the unforgotten master of mycological entertainment, the clinical eye is often a relative of the evil eye. He described the problem of

Company

Oncgnostics and EUROIMMUN Announce Collaboration to Distribute Cervical Cancer Test GynTect

Press Release Jena / Lübeck (GER) – Biotechnology company oncgnostics GmbH is announcing a collaboration with the international diagnostics group EUROIMMUN Medizinische Labordiagnostika AG. As part of the cooperation, EUROIMMUN will sell the cervical cancer test from oncgnostics GmbH, Gyn-Tect, in the European countries of Portugal, Italy, Turkey and Poland. The test is also expected

Scroll to Top